Ghagare
Maruti Ghagare, Thane (w) IN
Patent application number | Description | Published |
---|---|---|
20120116071 | Rifaximin - Amorphous rifaximin, methods of making it, and pharmaceutical compositions containing it. Also described are methods of converting amorphous rifaximin to crystalline rifaximin and vice versa. | 05-10-2012 |
20120220778 | Process for the synthesis of naratriptan - The present invention relates to a process for preparing naratriptan or a salt thereof, the process comprising: (a) reacting a compound of formula (3) with a compound of the formula HCCR | 08-30-2012 |
20130160761 | Pharmaceutical Aerosol Composition - A pharmaceutical aerosol composition comprising at least one hydrofluoroalkane propellant; at least one active agent complexed with an adjuvant; and, optionally, at least one pharmaceutically acceptable excipient. | 06-27-2013 |
20140256004 | Process for the Preparation of an Endothelin Receptor Antagonist - The present invention relates to a novel process for the preparation of a compound of formula (I) wherein R is a methyl or methoxy group; to certain novel intermediates prepared in such a process and their use. | 09-11-2014 |
Maruti Ghagare, Maharashtra IN
Patent application number | Description | Published |
---|---|---|
20090312357 | Rifaximin - Amorphous rifaximin, methods of making it, and pharmaceutical compositions containing it. Also described are methods of converting amorphous rifaximin to crystalline rifaximin and vice versa. | 12-17-2009 |
20110184174 | Processes for the Synthesis of Levocetirizine and Intermediates for Use Therein - The present invention provides a compound of formula (IV) | 07-28-2011 |
Maruti Ghagare, Thane (west) IN
Maruti Ghagare, Thane (west) Maharashtra IN
Patent application number | Description | Published |
---|---|---|
20150197523 | PROCESS FOR THE PREPARATION OF SITAGLIPTIN AND INTERMEDIATE COMPOUNDS - There is provided a process for the preparation of sitagliptin or a pharmaceutically acceptable salt thereof, and a process for the preparation of intermediate compounds useful in the preparation of sitagliptin. In particular, there is provided a process comprising condensing 3-tert-butoxycarbonylamino-4-(2,4,5-trifluorophenyl)butyric acid of formula (II) with 3-(trifluoromethyl)-5,6,7,8-tetrahydro-[1,2,4]triazolo[4,3-a]pyrazine of formula (III) or a salt thereof in presence of a catalyst to obtain (R)-tert-butyl-4-oxo-4-(3-(trifluoromethyl)-5,6-dihydro-[1,2,4]-triazolo[4,3-a]pyrazin-7(8H)-yl)-1-(2,4,5-trifluorophenyl)butan-2-yl-carbamate of formula (IV) or a pharmaceutically acceptable salt thereof. The catalyst is represented by the compound of formula (V). Compound of formula (IV) or its pharmaceutically acceptable salt obtained may be deprotected to obtain a compound of formula (I). | 07-16-2015 |
Maruti Ganpati Ghagare, Maharashtra IN
Patent application number | Description | Published |
---|---|---|
20100228052 | PROCESS FOR THE SYNTHESIS OF IBANDRONATE SODIUM - The present invention relates to an improved process for the synthesis of Ibandronate sodium of formula (I). The present invention also provides novel processes for the synthesis of 3-[N-(methylpentyl)amino]propionic acid (III). | 09-09-2010 |
20110245499 | Process for Resolving Zopiclone - The present invention provides a process for the preparation of the dextrorotatory isomer of zopiclone (eszopiclone). The present invention also provides eszopiclone di-p-anisolyl-L-tartrate and eszopiclone diacetyl-L-tartrate, which are useful as intermediates in a process for preparing eszopiclone. | 10-06-2011 |
20110262378 | Rifaximin Complexes - There is provided a complex comprising rifaximin and a complexing agent, wherein the complexing agent is a polyvinyl pyrrolidone (PVP) or a cyclodextrin. There is also provided a process for preparing the complex, a pharmaceutical composition including the complex, and therapeutic uses of the complex. | 10-27-2011 |
Maruti Ganpati Ghagare, Thane (w) IN
Patent application number | Description | Published |
---|---|---|
20120232091 | Polymorphic Forms of Manidipine - The invention relates to various new polymorphic forms of manidipine and pharmaceutically acceptable salts thereof. The invention also relates to processes for the preparation of the polymorphic forms of manidipine and pharmaceutically acceptable salts thereof. | 09-13-2012 |
Maruti Ganpati Ghagare, Mumbai IN
Patent application number | Description | Published |
---|---|---|
20150037275 | RIFAXIMIN COMPLEXES - There is provided a complex comprising rifaximin and a complexing agent, wherein the complexing agent is a polyvinyl pyrrolidone (PVP) or a cyclodextrin. There is also provided a process for preparing the complex, a pharmaceutical composition including the complex and therapeutic uses of the complex. | 02-05-2015 |
20150045382 | RIFAXIMIN COMPLEXES - There is provided a complex comprising rifaximin and a complexing agent, wherein the complexing agent is a polyvinyl pyrrolidone (PVP) or a cyclodextrin. There is also provided a process for preparing the complex, a pharmaceutical composition including the complex and therapeutic uses of the complex. | 02-12-2015 |